ClinicalTrials.gg
Not yet recruitingNCT07636330Updated Jul 2, 2026

Virtual Reality for Pain and Anxiety in Pediatric Dental Treatment

An interventional study of Immersive Virtual Reality Headset and Standard Behaviour Guidance in Dental Anxiety in Children and Pain, sponsored by University of British Columbia. Not yet recruiting at 1 site in Canada. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-02.

Sponsored by University of British Columbia · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether immersive virtual reality (VR) reduces pain and anxiety in children aged 6-12 years during routine dental procedures. The main questions it aims to answer are:

  • Does VR distraction reduce self-reported pain and anxiety during dental treatment compared to standard behaviour guidance?
  • Does VR distraction improve children's post-procedural experience and willingness to return for future dental visits?

Researchers will compare children using a VR headset during dental treatment to children receiving standard behaviour guidance techniques.

Participants will:

  • Attend one routine dental appointment
  • Be randomly assigned to wear a VR headset or receive standard care during their procedure
  • Complete brief questionnaires about pain and anxiety before and after treatment
  • Receive a follow-up phone call 24-72 hours after the appointment
02

Conditions studied

  • Dental Anxiety in Children
  • Pain

Keywords

  • Distraction
  • Virtual reality
  • Pediatric Dentistry
  • Dental Anxiety
  • Procedural Pain
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 80 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,339 studies on the registry; 259 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 6 to 12 years
  • Scheduled for a routine invasive dental procedure
  • Accompanied by a parent or legal guardian
  • Parent/guardian able to provide written

Exclusion criteria

Exclusion Criteria:

  • Children with visual or hearing impairments that would prevent use of the VR headset
  • Children with a history of motion sickness
  • Children with severe cognitive or developmental delays that would prevent completion of study measures
  • Children who have previously participated in this study
  • Children requiring emergency dental treatment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    VR Distraction

    Children wear an immersive VR headset during routine dental treatment as a non-pharmacological distraction intervention. The VR headset provides an engaging visual and auditory environment to reduce pain and anxiety during the procedure.

    Device: Immersive Virtual Reality Headset

  • Active comparator
    Standard Behaviour Guidance

    Children receive standard behaviour guidance techniques commonly used in pediatric dentistry, such as tell-show-do and positive reinforcement, without VR distraction.

    Behavioral: Standard Behaviour Guidance

Interventions

  • DeviceImmersive Virtual Reality Headset

    A commercially available immersive VR headset used as a non-pharmacological distraction tool during routine pediatric dental procedures. Children wear the headset throughout their treatment to engage with an interactive virtual environment designed to reduce pain and anxiety.

  • BehavioralStandard Behaviour Guidance

    Standard behaviour guidance techniques routinely used in pediatric dentistry, including tell-show-do, positive reinforcement, and distraction through verbal communication and a TV screen. No virtual reality headset is used.

06

What researchers measure

Primary outcomes

  1. Self-Reported Pain During Dental Procedure Using Faces Pain Scale

    Child self-reported pain assessed using the Faces Pain Scale (0-10 where 10 is the maximum pain felt): The child is asked to point to the Faces picture that reflect the pain level that they are feeling. 0= Relaxed and comfortable; 2-4= Mild discomfort; 6-8= Moderate pain; 10= Severe pain or discomfort Baseline pre-procedural and immediately following the dental procedure.

    Time frame: Baseline Pre-procedural and Immediately following the dental procedure (same day)

Secondary outcomes

  1. Physiological Stress Response (Salivary alpha-Amylase) salivary alpha-amylase level (U/L) baseline before any dental treatment and immediately following the dental procedure

    Using a swab to collect for a full 60-90 seconds by resting the swab inside the mouth, or collect in intervals by re-introducing the swab into the mouth as needed, until the lower third of the swab is saturated (some participants may require longer than 90 seconds of total collection time). Salivary alpha-amylase level (U/L), measured at baseline (immediately prior to the start of the dental procedure) and again immediately following the dental procedure. Both samples are collected on the same day, during the single dental appointment.

    Time frame: Salivary alpha-amylase level (U/L), measured at baseline (immediately prior to the start of the dental procedure) and again immediately following the dental procedure. Both samples are collected on the same day, during the single dental appointment.

  2. Physiological Stress Response (Heart Rate)

    Physiological markers of stress assessed via heart rate using a pulse oximeter device (pulse/minute)

    Time frame: Baseline (Before the procedure), during and Immediately following the dental procedure

07

Study locations

1 site
  • UBC Graduate Pediatric Dental Clinic
    Vancouver, British Columbia V6T 1Z3, Canada
08

References and documents

Individual participant data

Plan to share: Undecided — A decision regarding individual participant data sharing has not yet been made. This study involves children (a vulnerable population) and data sharing plans will be determined in accordance with UBC Research Ethics Board requirements

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Jun 2027, 12 months later.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 12 months is above that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2026
First posted
Jun 9, 2026
StartEst.
Jun 2, 2026
Primary completionEst.
Jun 18, 2027
CompletionEst.
Jun 30, 2027
Last update
Jul 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07636330
Responsible party
Randa Soussou (University of British Columbia, University of British Columbia) — Principal investigator
First posted
Jun 9, 2026
Start date
Jun 2, 2026 (estimated)
Primary completion
Jun 18, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jul 2, 2026

Study contacts

Randa Soussou
Contact
randa.soussou@dentistry.ubc.ca
604-822-6819

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion